Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI).
- Citation:
- Br J Haematol vol 151 (2) 143-51
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Older Adult
- Sec. Committees:
- Health Outcomes
- Pharmas:
- Grants:
- CA11083, CA13650, CA16450, CA21115, CA23318, CA32291, CA35431, CA66636, U10 CA011083, U10 CA013650, U10 CA021115, U10 CA023318, U10 CA032291, U10 CA035431, U10 CA066636, U24 CA114737
- Corr. Author:
- Authors:
- Ranjana H Advani Haiyan Chen Thomas M Habermann Vicki A Morrison Edie A Weller Richard I Fisher Bruce A Peterson Randy D Gascoyne Sandra J Horning
- Networks:
- Study
- Alliance-9793
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords:
- Age Factors, Aged, Aged, 80 and over, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Drug Administration Schedule, Epidemiologic Methods, Health Status Indicators, Humans, Lymphoma, Large B-Cell, Diffuse, Middle Aged, Prednisone, Prognosis, Treatment Outcome, Vincristine